Lipella Pharmaceuticals Inc. Other Nonoperating Income (Expense)
Lipella Pharmaceuticals Inc. (LIPO) reported Other Nonoperating Income (Expense) of -$45 for the 9-month period ending 2022-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2023-11-14
- Lipella Pharmaceuticals Inc. other nonoperating income (expense) for the quarter ending 2022-09-30 was $0.00.
- Lipella Pharmaceuticals Inc. other nonoperating income (expense) for the quarter ending 2022-06-30 was $156.00.
- Lipella Pharmaceuticals Inc. other nonoperating income (expense) for the quarter ending 2022-03-31 was -$201.00.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month |
|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $156.00 derived: sum of 2 quarters · filed 2023-11-14 | -$45.00 10-Q · filed 2023-11-14 |
| 2022-06-30 | $156.00 10-Q · filed 2023-08-14 | -$45.00 10-Q · filed 2023-08-14 | |
| 2022-03-31 | -$201.00 10-Q · filed 2023-05-12 |